Status:

COMPLETED

Diabetes and Gastric By- Pass

Lead Sponsor:

University of Texas Southwestern Medical Center

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

18-65 years

Brief Summary

The purpose of this study is to evaluate the mechanisms leading to rapid postoperative improvement in diabetes following Gastric By-Pass surgery for obesity.We will evaluate and compare the changes in...

Detailed Description

Volunteers planned to undergo RYGB will be studied during two-9 days periods of identical and controlled diet and activity, separated by a 4-10-week washout period. Study Period #1: This first study...

Eligibility Criteria

Inclusion

  • volunteers that are planned to undergo RYGB(Roux-en-Y By pass) and have type 2 diabetes diagnosed within the prior 10 years.

Exclusion

  • abnormal renal function
  • significant anemia
  • difficult venous access
  • treatment with incretin mimetics or DPP IV inhibitors in the prior 3 months
  • recent change in use of any pharmacologic agent with potential effect on either beta-cell function or insulin resistance.
  • pregnancy
  • non -English speakers

Key Trial Info

Start Date :

June 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT01153516

Start Date

June 1 2010

End Date

December 1 2012

Last Update

March 27 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical and Translational Research Center

Dallas, Texas, United States, 75390